Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

87 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Do patients participating in clinical trials want to know study results?
Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP. Partridge AH, et al. J Natl Cancer Inst. 2003 Mar 19;95(6):491-2. doi: 10.1093/jnci/95.6.491. J Natl Cancer Inst. 2003. PMID: 12644548 No abstract available.
Dose density in breast cancer: a simple message?
Lin NU, Gelman R, Winer EP. Lin NU, et al. J Natl Cancer Inst. 2005 Dec 7;97(23):1712-4. doi: 10.1093/jnci/dji438. J Natl Cancer Inst. 2005. PMID: 16333021 No abstract available.
Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants.
Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, Bauer-Wu S, Knudsen K, Emmons K, Collyar D, Schilsky RL, Winer EP. Partridge AH, et al. J Natl Cancer Inst. 2004 Apr 21;96(8):629-32. doi: 10.1093/jnci/djh096. J Natl Cancer Inst. 2004. PMID: 15100341
Assessment of adjuvant trials in breast cancer.
Zelen M, Gelman R. Zelen M, et al. NCI Monogr. 1986;(1):11-7. NCI Monogr. 1986. PMID: 3774010
Duration of therapy in adjuvant chemotherapy trials.
Henderson IC, Gelman RS, Harris JR, Canellos GP. Henderson IC, et al. NCI Monogr. 1986;(1):95-8. NCI Monogr. 1986. PMID: 3534596 Clinical Trial.
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
Burstein HJ, Keshaviah A, Baron AD, Hart RD, Lambert-Falls R, Marcom PK, Gelman R, Winer EP. Burstein HJ, et al. Cancer. 2007 Sep 1;110(5):965-72. doi: 10.1002/cncr.22885. Cancer. 2007. PMID: 17614302 Clinical Trial.
PIK3CA mutations in in situ and invasive breast carcinomas.
Miron A, Varadi M, Carrasco D, Li H, Luongo L, Kim HJ, Park SY, Cho EY, Lewis G, Kehoe S, Iglehart JD, Dillon D, Allred DC, Macconaill L, Gelman R, Polyak K. Miron A, et al. Cancer Res. 2010 Jul 15;70(14):5674-8. doi: 10.1158/0008-5472.CAN-08-2660. Epub 2010 Jun 15. Cancer Res. 2010. PMID: 20551053 Free PMC article.
Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.
Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, Gelman R, Brennan C, Polyak K. Yao J, et al. Cancer Res. 2006 Apr 15;66(8):4065-78. doi: 10.1158/0008-5472.CAN-05-4083. Cancer Res. 2006. PMID: 16618726
A putative role for psoriasin in breast tumor progression.
Krop I, März A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, Kleer CG, Enerbäck C, Polyak K. Krop I, et al. Cancer Res. 2005 Dec 15;65(24):11326-34. doi: 10.1158/0008-5472.CAN-05-1523. Cancer Res. 2005. PMID: 16357139
HIN-1, an inhibitor of cell growth, invasion, and AKT activation.
Krop I, Parker MT, Bloushtain-Qimron N, Porter D, Gelman R, Sasaki H, Maurer M, Terry MB, Parsons R, Polyak K. Krop I, et al. Cancer Res. 2005 Nov 1;65(21):9659-69. doi: 10.1158/0008-5472.CAN-05-1663. Cancer Res. 2005. PMID: 16266985
87 results
Jump to page
Feedback